Cambridge, MA, United States of America

Zinkal Samir Padalia

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Zinkal Samir Padalia: Innovator in Cancer Treatment

Introduction

Zinkal Samir Padalia is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative methods and compositions. With a total of 3 patents, Padalia is recognized for his dedication to advancing medical science.

Latest Patents

His latest patents focus on methods and compositions for treating cancer. These patents provide innovative approaches, including cell compositions, aimed at improving cancer treatment outcomes. The emphasis on developing effective methods showcases his commitment to addressing critical health challenges.

Career Highlights

Zinkal Padalia is currently associated with Crispr Therapeutics AG, a company known for its groundbreaking work in gene editing and therapeutic solutions. His role at the company allows him to collaborate with leading experts in the field, further enhancing his contributions to cancer research.

Collaborations

Padalia has worked alongside notable colleagues, including Jonathan Alexander Terrett and Demetrios Kalaitzidis. These collaborations have fostered a dynamic environment for innovation and research, leading to advancements in cancer treatment methodologies.

Conclusion

Zinkal Samir Padalia stands out as a dedicated inventor in the realm of cancer treatment. His innovative patents and collaborations reflect his commitment to improving healthcare solutions. Through his work, he continues to make a significant impact in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…